This item is authorised by the following title:
This Exemption ends on 30 April 2010, or when the product receives a marketing approval in Australia for the prevention and early treatment of suspected smallpox infection in humans, whichever occurs first.
This Exemption ends on 30 April 2010, or when the product receives a marketing approval in Australia for the prevention and early treatment of suspected smallpox infection in humans, whichever occurs first.